Voriconazole in lung transplant recipients - how worried should we be?

被引：5
|
作者：
Kulkarni, Hrishikesh S. [1 ]
Witt, Chad A. [1 ]
机构：
[1] Washington Univ, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63130 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷 / 01期
基金：
美国国家卫生研究院;
关键词：
cancer/malignancy/neoplasia: skin - nonmelanoma; clinical research/practice; immunosuppressant; lung transplantation/pulmonology; EXPOSURE; CANCER; RISK;
D O I：
10.1111/ajt.14517
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
The authors comment on Hamandi et al's insights (page 113) into the risk versus benefit of using voriconazole in lung transplant recipients, given the increasingly accepted risk of squamous cell carcinoma.
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [1] HOW WORRIED SHOULD WE BE
    不详
    POLITICAL QUARTERLY, 1989, 60 (01): : 1 - 3
  • [2] Voriconazole prophylaxis in lung transplant recipients
    Husain, S.
    Paterson, D. L.
    Studer, S.
    Pilewski, J.
    Crespo, M.
    Zaldonis, D.
    Shutt, K.
    Pakstis, D. L.
    Zeevi, A.
    Johnson, B.
    Kwak, E. J.
    McCurry, K. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) : 3008 - 3016
  • [3] Preemptive treatment with voriconazole in lung transplant recipients
    Neoh, C. F.
    Snell, G. I.
    Levvey, B.
    Kotsimbos, T.
    Morrissey, C. O.
    Slavin, M. A.
    Stewart, K.
    Kong, D. C. M.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (04) : 344 - 353
  • [4] Malignancy and Augmentation-How Worried Should We Be?
    Krupski, Tracey L.
    JOURNAL OF UROLOGY, 2010, 184 (06): : 2231 - 2232
  • [5] The upcoming flu seasons: how worried should we be?
    Kayali, Ghazi
    LANCET GLOBAL HEALTH, 2022, 10 (11): : E1543 - E1544
  • [6] HOW WORRIED SHOULD WE BE ABOUT RISING INFLATION?
    Hausman, Joshua K.
    JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 2023, 42 (01) : 305 - 322
  • [7] How worried should we be about reports of reinfection?
    Hamzelou, Jessica
    NEW SCIENTIST, 2020, 245 (3300) : 14 - 15
  • [8] We should be worried
    Anderson, R
    GEOTIMES, 2001, 46 (04): : 4 - 4
  • [9] Risk Factors for Voriconazole Hepatotoxicity in Lung Transplant Recipients
    Luong, M. -L
    Hosseini-Moghaddam, S. M.
    Singer, L. G.
    Chapparo, C.
    Keshavjee, S.
    Lazar, N.
    Azad, S.
    Rotstein, C.
    Husain, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S147 - S147
  • [10] Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients
    Han, Kelong
    Capitano, B.
    Bies, R.
    Potoski, B. A.
    Husain, S.
    Gilbert, S.
    Paterson, D. L.
    McCurry, K.
    Venkataramanan, R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4424 - 4431
12345